Rxsight Inc
NASDAQ:RXST
Rxsight Inc
NASDAQ:RXST
Price:
7.33
USD
-4.06%
Market Closed
Market Cap:
$301.4m
Relative Value
The Relative Value of one
RXST
stock under the Base Case scenario is
14.46
USD.
Compared to the current market price of 7.33 USD,
Rxsight Inc
is
Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RXST
Relative Value
Base Case
14.46
USD
Undervaluation 49%
Multiples Across Competitors
RXST Competitors Multiples
Rxsight Inc Competitors
Rxsight Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Rxsight Inc
NASDAQ:RXST
|
302.3m USD | 2.2 | -7.4 | -1.4 | -1.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.2 | 37.5 | 27.1 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
54.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.8B CHF | 3.7 | 39 | 15 | 29.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.3B DKK | 3.7 | 25.6 | 13.4 | 16 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD | 2.9 | 28.6 | 12.3 | 16.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.6 | 36 | 14.3 | 24.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.8B CNY | 9.2 | 25.3 | 22.8 | 22.8 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.9 | 17 | 55.2 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD | 3.3 | 21.9 | 14 | 17.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
819.6B JPY | 6.3 | 46.3 | 21.8 | 29.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
